| Author | Andrade, Ana F. B. | |
| Author | Silva, Michelle Oliveira | |
| Author | Silva, Suely G. C. | |
| Author | Motta, Iara J. F. | |
| Author | Bonvicino, Cibele R. | |
| Access date | 2019-12-19T17:04:58Z | |
| Available date | 2019-12-19T17:04:58Z | |
| Document date | 2006 | |
| Citation | ANDRADE, Ana F. B. et al. Seroprevalence of hepatitis B and C virus markers among blood donors in Rio de Janeiro, Brazil, 1998-2005. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v. 101, n.6, p. 673-676, Sept. 2006. | pt_BR |
| ISSN | 0074-0206 | pt_BR |
| URI | https://www.arca.fiocruz.br/handle/icict/38723 | |
| Language | eng | pt_BR |
| Publisher | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz | pt_BR |
| Rights | open access | |
| Subject in Portuguese | Vírus da Hepatite B | pt_BR |
| Subject in Portuguese | Vírus da Hepatite c | pt_BR |
| Subject in Portuguese | Doadores de sangue | pt_BR |
| Subject in Portuguese | Soroprevalência | pt_BR |
| Subject in Portuguese | Brasil | pt_BR |
| Title | Seroprevalence of hepatitis B and C virus markers among blood donors in Rio de Janeiro, Brazil, 1998-2005 | pt_BR |
| Type | Article | |
| DOI | 10.1590/s0074-02762006000600016 | |
| Abstract | The prevalence of infection by hepatitis B (HBV) and C (HCV) viruses varies among geographical regions. In order to determine the prevalence of HBV and HCV infection in voluntary blood donors we evaluated the prevalence of HBsAg, anti-HBc, and anti-HCV markers of 128,497 blood donor samples collected from 1998 to 2005 in the state of Rio de Janeiro. These markers were analyzed by immunoenzymatic tests, as determined by the Ministry of Health. Data were obtained from the Sorology Laboratory of the Hemotherapy Service of the Instituto Nacional de Câncer, Rio de Janeiro. Overall prevalence estimates were: 0.27% for HBsAg, 3.68% for anti-HBc, and 0.90% for anti-HCV. There was a significant decrease in the overall prevalence of HBsAg (from 0.36 to 0.14%) and anti-HBc (from 6.12 to 2.05%) in the period encompassed between 1998-2005. Similarly, there was a decline in anti-HCV prevalence rates in Brazilian blood donors, from 1.04% in 1998 to 0.79% in 2004, with an increase of HCV prevalence to 1.09% in 2005. These prevalence estimates were higher than those found in other countries, indicating high rates of infection by HBV and HCV and a persistent risk of HBV and HCV transmission by transfusion. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Programa de Pós-Graduação em Biologia Celular e Molecular. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Affilliation | Instituto Nacional de Câncer. Divisão de Genética. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Affilliation | Instituto Nacional de Câncer. Laboratório de Sorologia. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Affilliation | Instituto Nacional de Câncer. Laboratório de Sorologia. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Departamento de Medicina Tropical. Rio de Janeiro, RJ, Brasil / Instituto Nacional de Câncer. Divisão de Genética. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Subject | Hepatitis B virus | pt_BR |
| Subject | Hepatitis C virus | pt_BR |
| Subject | Blood donors | pt_BR |
| Subject | Seroprevalence | pt_BR |
| Subject | Brazil | pt_BR |
| e-ISSN | 1678-8060 | |
